VALLOUREC CONFIRMS ITS INTENTION TO RETURN CLOSE TO €650 MILLION TO SHAREHOLDERS IN 2026 FOLLOWING THE COMPLETION OF ITS ...
Explore Novartis AG-Sponsored ADR, healthcare operations, pharmaceutical research, global manufacturing, therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results